Bioequivalence for Parenteral Products [Regulatives / Guidelines]

posted by arailkar – 2020-05-29 19:21 (1750 d 18:29 ago) – Posting: # 21491
Views: 2,401

Dear Helmut,

I am interested in finding out if bioequivalence study is needed in the US when an IV formulation is changed to a subcutaneous formulation. I would also appreciate if you can please give me references to US FDA Guidance document that addresses this topic. Thank you very much.

Regards,
Ani

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,662 registered users;
17 visitors (0 registered, 17 guests [including 11 identified bots]).
Forum time: 12:50 CET (Europe/Vienna)

Tortured data will confess to anything.    Fredric Menger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5